ABIO
ARCA biopharma Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| 11-14-2018 | 08-09-2018 | 05-08-2018 | 03-22-2018 | 11-09-2017 | 08-03-2017 | |
|---|---|---|---|---|---|---|
| Actual EPS | -0.11 | -0.15 | -0.2 | -0.34 | -0.39 | -0.59 |
| Consensus EPS | ||||||
| Estimated EPS | ||||||
| Number of Estimates | ||||||
| EPS Surprise |
Stats
Summary
ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.
Market Cap: 21.7 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.arcabiopharma.com
Shares Outstanding: 11.8 Million
Float: 11.3 Million
Dividend: 0.0 (0.0%)
Beta: 1.211096
Sector: Healthcare
Industry: Biotechnology
Short Interest (Jan 12, 2018): 116 Thousand
Ethical Flags
Longest drawdown: 1630 trading days
From: 2013-01-31 To: 2019-02-20
Lowest Point:
ARCA Biopharma up 141% after FDA agreement for Phase 3 trial of Gencaro
via: SeekingAlpha at 2019-02-20 09:03:26:000
ARCA Biopharma(NASDAQ: ABIO ) has reached agreement with the FDA on the design of a Phase 3 clinical trial, PRECISION-AF, evaluating Gencaro(bucindolol hydrochloride) versus Toprol-XL (metoprolol succinate) for the treatment of atrial fibrillation (AF) in patients with a specif… read more...
ARCA Biopharma up 141% after FDA agreement for Phase 3 trial of Gencaro
via: SeekingAlpha at 2019-02-20 09:03:26:000
ARCA Biopharma(NASDAQ: ABIO ) has reached agreement with the FDA on the design of a Phase 3 clinical trial, PRECISION-AF, evaluating Gencaro(bucindolol hydrochloride) versus Toprol-XL (metoprolol succinate) for the treatment of atrial fibrillation (AF) in patients with a specif… read more...
ARCA biopharma reports Q3 results
via: SeekingAlpha at 2018-11-14 16:42:07:000
ARCA biopharma (NASDAQ: ABIO ): Q3 GAAP EPS of -$0.11. More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q3 results
via: SeekingAlpha at 2018-11-14 16:42:07:000
ARCA biopharma (NASDAQ: ABIO ): Q3 GAAP EPS of -$0.11. More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q3 results
via: SeekingAlpha at 2018-11-14 16:42:07:000
ARCA biopharma (NASDAQ: ABIO ): Q3 GAAP EPS of -$0.11. More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q3 results
via: SeekingAlpha at 2018-11-14 16:42:07:000
ARCA biopharma (NASDAQ: ABIO ): Q3 GAAP EPS of -$0.11. More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q3 results
via: SeekingAlpha at 2018-11-14 16:42:07:000
ARCA biopharma (NASDAQ: ABIO ): Q3 GAAP EPS of -$0.11. More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q3 results
via: SeekingAlpha at 2018-11-14 16:42:07:000
ARCA biopharma (NASDAQ: ABIO ): Q3 GAAP EPS of -$0.11. More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q3 results
via: SeekingAlpha at 2018-11-14 16:42:07:000
ARCA biopharma (NASDAQ: ABIO ): Q3 GAAP EPS of -$0.11. More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q3 results
via: SeekingAlpha at 2018-11-14 16:42:07:000
ARCA biopharma (NASDAQ: ABIO ): Q3 GAAP EPS of -$0.11. More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q3 results
via: SeekingAlpha at 2018-11-14 16:42:07:000
ARCA biopharma (NASDAQ: ABIO ): Q3 GAAP EPS of -$0.11. More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q3 results
via: SeekingAlpha at 2018-11-14 16:42:07:000
ARCA biopharma (NASDAQ: ABIO ): Q3 GAAP EPS of -$0.11. More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Midday Gainers / Losers (10/02/2018)
via: SeekingAlpha at 2018-10-02 12:44:16:000
Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...
Midday Gainers / Losers (10/02/2018)
via: SeekingAlpha at 2018-10-02 12:44:16:000
Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...
Midday Gainers / Losers (10/02/2018)
via: SeekingAlpha at 2018-10-02 12:44:16:000
Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...
Midday Gainers / Losers (10/02/2018)
via: SeekingAlpha at 2018-10-02 12:44:16:000
Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...
Midday Gainers / Losers (10/02/2018)
via: SeekingAlpha at 2018-10-02 12:44:16:000
Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...
Midday Gainers / Losers (10/02/2018)
via: SeekingAlpha at 2018-10-02 12:44:16:000
Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...
Midday Gainers / Losers (10/02/2018)
via: SeekingAlpha at 2018-10-02 12:44:16:000
Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...
Midday Gainers / Losers (10/02/2018)
via: SeekingAlpha at 2018-10-02 12:44:16:000
Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...
Midday Gainers / Losers (10/02/2018)
via: SeekingAlpha at 2018-10-02 12:44:16:000
Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...
Midday Gainers / Losers (10/02/2018)
via: SeekingAlpha at 2018-10-02 12:44:16:000
Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...
Midday Gainers / Losers (10/02/2018)
via: SeekingAlpha at 2018-10-02 12:44:16:000
Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...
Midday Gainers / Losers (10/02/2018)
via: SeekingAlpha at 2018-10-02 12:44:16:000
Gainers: OGEN +92% . DTEA +62% . IGC +58% . TRPX +49% . IMTE +43% . SLS +22% . SYN +20% . FTFT +19% . ATRS +19% . INO +18% . More news on: Oragenics, Inc., DAVIDs TEA, India Globalization Capital, Inc, , Stocks on the move, Top stock market news, R… read more...
Premarket Losers as of 9:05 am (10/2/2018)
via: SeekingAlpha at 2018-10-02 09:09:16:000
ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (10/2/2018)
via: SeekingAlpha at 2018-10-02 09:09:16:000
ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (10/2/2018)
via: SeekingAlpha at 2018-10-02 09:09:16:000
ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (10/2/2018)
via: SeekingAlpha at 2018-10-02 09:09:16:000
ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (10/2/2018)
via: SeekingAlpha at 2018-10-02 09:09:16:000
ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (10/2/2018)
via: SeekingAlpha at 2018-10-02 09:09:16:000
ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (10/2/2018)
via: SeekingAlpha at 2018-10-02 09:09:16:000
ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (10/2/2018)
via: SeekingAlpha at 2018-10-02 09:09:16:000
ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (10/2/2018)
via: SeekingAlpha at 2018-10-02 09:09:16:000
ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (10/2/2018)
via: SeekingAlpha at 2018-10-02 09:09:16:000
ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (10/2/2018)
via: SeekingAlpha at 2018-10-02 09:09:16:000
ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...
Premarket Losers as of 9:05 am (10/2/2018)
via: SeekingAlpha at 2018-10-02 09:09:16:000
ABIO -22% . More news on: ARCA biopharma, Inc., Stitch Fix, Inc., New Age Beverages Corporation, Stocks on the move, Top stock market news, , Read more … read more...
ARCA biopharma reports Q2 results
via: SeekingAlpha at 2018-08-09 16:52:26:000
ARCA biopharma (NASDAQ: ABIO ): Q2 EPS of -$0.15 More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q2 results
via: SeekingAlpha at 2018-08-09 16:52:26:000
ARCA biopharma (NASDAQ: ABIO ): Q2 EPS of -$0.15 More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q2 results
via: SeekingAlpha at 2018-08-09 16:52:26:000
ARCA biopharma (NASDAQ: ABIO ): Q2 EPS of -$0.15 More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q2 results
via: SeekingAlpha at 2018-08-09 16:52:26:000
ARCA biopharma (NASDAQ: ABIO ): Q2 EPS of -$0.15 More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q2 results
via: SeekingAlpha at 2018-08-09 16:52:26:000
ARCA biopharma (NASDAQ: ABIO ): Q2 EPS of -$0.15 More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q2 results
via: SeekingAlpha at 2018-08-09 16:52:26:000
ARCA biopharma (NASDAQ: ABIO ): Q2 EPS of -$0.15 More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports Q2 results
via: SeekingAlpha at 2018-08-09 16:52:26:000
ARCA biopharma (NASDAQ: ABIO ): Q2 EPS of -$0.15 More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
FDA on board with single Phase 3 to support marketing application for ARCA Bio's Gencaro; shares up 37% premarket
via: SeekingAlpha at 2018-07-31 09:11:15:000
Nano cap ARCA biopharma (NASDAQ: ABIO ) is up 37% premarket on robust volume in response to its announcement that the FDA has indicated that a single Phase 3 clinical trial may be sufficient to support a U.S. marketing application for Gencaro (bucindolol hydrochloride) for the … read more...
FDA on board with single Phase 3 to support marketing application for ARCA Bio's Gencaro; shares up 37% premarket
via: SeekingAlpha at 2018-07-31 09:11:15:000
Nano cap ARCA biopharma (NASDAQ: ABIO ) is up 37% premarket on robust volume in response to its announcement that the FDA has indicated that a single Phase 3 clinical trial may be sufficient to support a U.S. marketing application for Gencaro (bucindolol hydrochloride) for the … read more...
FDA on board with single Phase 3 to support marketing application for ARCA Bio's Gencaro; shares up 37% premarket
via: SeekingAlpha at 2018-07-31 09:11:15:000
Nano cap ARCA biopharma (NASDAQ: ABIO ) is up 37% premarket on robust volume in response to its announcement that the FDA has indicated that a single Phase 3 clinical trial may be sufficient to support a U.S. marketing application for Gencaro (bucindolol hydrochloride) for the … read more...
Your Daily Pharma Scoop: 4 NDAs... CPRX, EXEL, ALPMY, ACOR
via: SeekingAlpha at 2018-05-31 04:17:16:000
Analysis Focus: CPRX Catalyst Pharmaceuticals (CPRX) is a smallcap company with $363M in market capitalization. The company was founded as Catalyst Pharmaceutical Partners, Inc. in 2002 and is based in Coral Gables, Florida. Their focus is on development and commercialization of therapies … read more...
Your Daily Pharma Scoop: 4 NDAs... CPRX, EXEL, ALPMY, ACOR
via: SeekingAlpha at 2018-05-31 04:17:16:000
Analysis Focus: CPRX Catalyst Pharmaceuticals (CPRX) is a smallcap company with $363M in market capitalization. The company was founded as Catalyst Pharmaceutical Partners, Inc. in 2002 and is based in Coral Gables, Florida. Their focus is on development and commercialization of therapies … read more...
Your Daily Pharma Scoop: 4 NDAs... CPRX, EXEL, ALPMY, ACOR
via: SeekingAlpha at 2018-05-31 04:17:16:000
Analysis Focus: CPRX Catalyst Pharmaceuticals (CPRX) is a smallcap company with $363M in market capitalization. The company was founded as Catalyst Pharmaceutical Partners, Inc. in 2002 and is based in Coral Gables, Florida. Their focus is on development and commercialization of therapies … read more...
Your Daily Pharma Scoop: 4 NDAs... CPRX, EXEL, ALPMY, ACOR
via: SeekingAlpha at 2018-05-31 04:17:16:000
Analysis Focus: CPRX Catalyst Pharmaceuticals (CPRX) is a smallcap company with $363M in market capitalization. The company was founded as Catalyst Pharmaceutical Partners, Inc. in 2002 and is based in Coral Gables, Florida. Their focus is on development and commercialization of therapies … read more...
Your Daily Pharma Scoop: 4 NDAs... CPRX, EXEL, ALPMY, ACOR
via: SeekingAlpha at 2018-05-31 04:17:16:000
Analysis Focus: CPRX Catalyst Pharmaceuticals (CPRX) is a smallcap company with $363M in market capitalization. The company was founded as Catalyst Pharmaceutical Partners, Inc. in 2002 and is based in Coral Gables, Florida. Their focus is on development and commercialization of therapies … read more...
Your Daily Pharma Scoop: 4 NDAs... CPRX, EXEL, ALPMY, ACOR
via: SeekingAlpha at 2018-05-31 04:17:16:000
Analysis Focus: CPRX Catalyst Pharmaceuticals (CPRX) is a smallcap company with $363M in market capitalization. The company was founded as Catalyst Pharmaceutical Partners, Inc. in 2002 and is based in Coral Gables, Florida. Their focus is on development and commercialization of therapies … read more...
Your Daily Pharma Scoop: 4 NDAs... CPRX, EXEL, ALPMY, ACOR
via: SeekingAlpha at 2018-05-31 04:17:16:000
Analysis Focus: CPRX Catalyst Pharmaceuticals (CPRX) is a smallcap company with $363M in market capitalization. The company was founded as Catalyst Pharmaceutical Partners, Inc. in 2002 and is based in Coral Gables, Florida. Their focus is on development and commercialization of therapies … read more...
ARCA bio down 18% after presentation of mid-stage data on Gencaro
via: SeekingAlpha at 2018-05-29 11:34:13:000
Nano cap ARCA biopharma ( ABIO -17.5% ) slumps on 25% higher volume on the heels of the release of detailed results from the mid-stage GENETIC-HF study that failed to demonstrate a treatment of benefit from Gencaro (bucindolol hydrochloride) compared to TOPROL-XL (metoprolol succinate) i… read more...
ARCA bio down 18% after presentation of mid-stage data on Gencaro
via: SeekingAlpha at 2018-05-29 11:34:13:000
Nano cap ARCA biopharma ( ABIO -17.5% ) slumps on 25% higher volume on the heels of the release of detailed results from the mid-stage GENETIC-HF study that failed to demonstrate a treatment of benefit from Gencaro (bucindolol hydrochloride) compared to TOPROL-XL (metoprolol succinate) i… read more...
ARCA bio down 18% after presentation of mid-stage data on Gencaro
via: SeekingAlpha at 2018-05-29 11:34:13:000
Nano cap ARCA biopharma ( ABIO -17.5% ) slumps on 25% higher volume on the heels of the release of detailed results from the mid-stage GENETIC-HF study that failed to demonstrate a treatment of benefit from Gencaro (bucindolol hydrochloride) compared to TOPROL-XL (metoprolol succinate) i… read more...
ARCA bio down 18% after presentation of mid-stage data on Gencaro
via: SeekingAlpha at 2018-05-29 11:34:13:000
Nano cap ARCA biopharma ( ABIO -17.5% ) slumps on 25% higher volume on the heels of the release of detailed results from the mid-stage GENETIC-HF study that failed to demonstrate a treatment of benefit from Gencaro (bucindolol hydrochloride) compared to TOPROL-XL (metoprolol succinate) i… read more...
ARCA bio down 18% after presentation of mid-stage data on Gencaro
via: SeekingAlpha at 2018-05-29 11:34:13:000
Nano cap ARCA biopharma ( ABIO -17.5% ) slumps on 25% higher volume on the heels of the release of detailed results from the mid-stage GENETIC-HF study that failed to demonstrate a treatment of benefit from Gencaro (bucindolol hydrochloride) compared to TOPROL-XL (metoprolol succinate) i… read more...
ARCA bio down 18% after presentation of mid-stage data on Gencaro
via: SeekingAlpha at 2018-05-29 11:34:13:000
Nano cap ARCA biopharma ( ABIO -17.5% ) slumps on 25% higher volume on the heels of the release of detailed results from the mid-stage GENETIC-HF study that failed to demonstrate a treatment of benefit from Gencaro (bucindolol hydrochloride) compared to TOPROL-XL (metoprolol succinate) i… read more...
ARCA bio down 18% after presentation of mid-stage data on Gencaro
via: SeekingAlpha at 2018-05-29 11:34:13:000
Nano cap ARCA biopharma ( ABIO -17.5% ) slumps on 25% higher volume on the heels of the release of detailed results from the mid-stage GENETIC-HF study that failed to demonstrate a treatment of benefit from Gencaro (bucindolol hydrochloride) compared to TOPROL-XL (metoprolol succinate) i… read more...
Key events next week - healthcare
via: SeekingAlpha at 2018-05-18 16:37:17:000
Noteworthy events during the week of May 20 - 26 for healthcare investors: More news on: uniQure N.V., Roche Holding Ltd ADR, BioMarin Pharmaceutical Inc., Healthcare stocks news, , Read more … read more...
Key events next week - healthcare
via: SeekingAlpha at 2018-05-18 16:37:17:000
Noteworthy events during the week of May 20 - 26 for healthcare investors: More news on: uniQure N.V., Roche Holding Ltd ADR, BioMarin Pharmaceutical Inc., Healthcare stocks news, , Read more … read more...
Key events next week - healthcare
via: SeekingAlpha at 2018-05-18 16:37:17:000
Noteworthy events during the week of May 20 - 26 for healthcare investors: More news on: uniQure N.V., Roche Holding Ltd ADR, BioMarin Pharmaceutical Inc., Healthcare stocks news, , Read more … read more...
Key events next week - healthcare
via: SeekingAlpha at 2018-05-18 16:37:17:000
Noteworthy events during the week of May 20 - 26 for healthcare investors: More news on: uniQure N.V., Roche Holding Ltd ADR, BioMarin Pharmaceutical Inc., Healthcare stocks news, , Read more … read more...
Key events next week - healthcare
via: SeekingAlpha at 2018-05-18 16:37:17:000
Noteworthy events during the week of May 20 - 26 for healthcare investors: More news on: uniQure N.V., Roche Holding Ltd ADR, BioMarin Pharmaceutical Inc., Healthcare stocks news, , Read more … read more...
ARCA Biopharma and Medtronic extend Gencaro clinical trial collaboration agreement
via: SeekingAlpha at 2018-04-23 08:47:03:000
ARCA Biopharma (NASDAQ: ABIO ) announces that Medtronic (NYSE: MDT ) has extended the U.S., Canadian and European Clinical Trial Collaboration Agreement for an additional year to April 2019. More news on: ARCA biopharma, Inc., Medtronic plc, Healthcare stocks news, Stocks on the move, … read more...
ARCA Biopharma and Medtronic extend Gencaro clinical trial collaboration agreement
via: SeekingAlpha at 2018-04-23 08:47:03:000
ARCA Biopharma (NASDAQ: ABIO ) announces that Medtronic (NYSE: MDT ) has extended the U.S., Canadian and European Clinical Trial Collaboration Agreement for an additional year to April 2019. More news on: ARCA biopharma, Inc., Medtronic plc, Healthcare stocks news, Stocks on the move, … read more...
ARCA Biopharma and Medtronic extend Gencaro clinical trial collaboration agreement
via: SeekingAlpha at 2018-04-23 08:47:03:000
ARCA Biopharma (NASDAQ: ABIO ) announces that Medtronic (NYSE: MDT ) has extended the U.S., Canadian and European Clinical Trial Collaboration Agreement for an additional year to April 2019. More news on: ARCA biopharma, Inc., Medtronic plc, Healthcare stocks news, Stocks on the move, … read more...
ARCA Biopharma and Medtronic extend Gencaro clinical trial collaboration agreement
via: SeekingAlpha at 2018-04-23 08:47:03:000
ARCA Biopharma (NASDAQ: ABIO ) announces that Medtronic (NYSE: MDT ) has extended the U.S., Canadian and European Clinical Trial Collaboration Agreement for an additional year to April 2019. More news on: ARCA biopharma, Inc., Medtronic plc, Healthcare stocks news, Stocks on the move, … read more...
ARCA Biopharma and Medtronic extend Gencaro clinical trial collaboration agreement
via: SeekingAlpha at 2018-04-23 08:47:03:000
ARCA Biopharma (NASDAQ: ABIO ) announces that Medtronic (NYSE: MDT ) has extended the U.S., Canadian and European Clinical Trial Collaboration Agreement for an additional year to April 2019. More news on: ARCA biopharma, Inc., Medtronic plc, Healthcare stocks news, Stocks on the move, … read more...
ARCA Biopharma and Medtronic extend Gencaro clinical trial collaboration agreement
via: SeekingAlpha at 2018-04-23 08:47:03:000
ARCA Biopharma (NASDAQ: ABIO ) announces that Medtronic (NYSE: MDT ) has extended the U.S., Canadian and European Clinical Trial Collaboration Agreement for an additional year to April 2019. More news on: ARCA biopharma, Inc., Medtronic plc, Healthcare stocks news, Stocks on the move, … read more...
ARCA biopharma reports FY results
via: SeekingAlpha at 2018-03-22 16:37:46:000
ARCA biopharma (NASDAQ: ABIO ): FY EPS of -$1.77 More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports FY results
via: SeekingAlpha at 2018-03-22 16:37:46:000
ARCA biopharma (NASDAQ: ABIO ): FY EPS of -$1.77 More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
ARCA biopharma reports FY results
via: SeekingAlpha at 2018-03-22 16:37:46:000
ARCA biopharma (NASDAQ: ABIO ): FY EPS of -$1.77 More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Arca Biopharma Has One More Shot To Get It Right
via: SeekingAlpha at 2018-03-01 17:23:13:000
Recently, Arca Biopharma ( ABIO ) announced results for its phase 2b trial treating patients with atrial fibrillation (AF) and left ventricular ejection fraction ((HFrEF)). The failed phase 2b trial data caused the stock to tumble by more than 60%. On the outset, the data as a totality of … read more...
Arca Biopharma Has One More Shot To Get It Right
via: SeekingAlpha at 2018-03-01 17:23:13:000
Recently, Arca Biopharma ( ABIO ) announced results for its phase 2b trial treating patients with atrial fibrillation (AF) and left ventricular ejection fraction ((HFrEF)). The failed phase 2b trial data caused the stock to tumble by more than 60%. On the outset, the data as a totality of … read more...
Arca Biopharma Has One More Shot To Get It Right
via: SeekingAlpha at 2018-03-01 17:23:13:000
Recently, Arca Biopharma ( ABIO ) announced results for its phase 2b trial treating patients with atrial fibrillation (AF) and left ventricular ejection fraction ((HFrEF)). The failed phase 2b trial data caused the stock to tumble by more than 60%. On the outset, the data as a totality of … read more...
3 Things In Biotech You Should Learn Today: February 27, 2018
via: SeekingAlpha at 2018-02-28 08:00:00:000
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. Arca Bio crushed on poor heart trial results Company: Arca Bio ( ABIO ) Therapy: Buci… read more...
3 Things In Biotech You Should Learn Today: February 27, 2018
via: SeekingAlpha at 2018-02-28 08:00:00:000
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. Arca Bio crushed on poor heart trial results Company: Arca Bio ( ABIO ) Therapy: Buci… read more...
3 Things In Biotech You Should Learn Today: February 27, 2018
via: SeekingAlpha at 2018-02-28 08:00:00:000
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. Arca Bio crushed on poor heart trial results Company: Arca Bio ( ABIO ) Therapy: Buci… read more...
ARCA biopharma (ABIO) Top-Line Data From Genetic-AF Phase 2B Clinical Trial - Slideshow'
via: SeekingAlpha at 2018-02-27 13:50:17:000
The following slide deck was published by ARCA biopharma, Inc. in conjunction with this Read more … read more...
ARCA biopharma (ABIO) Top-Line Data From Genetic-AF Phase 2B Clinical Trial - Slideshow'
via: SeekingAlpha at 2018-02-27 13:50:17:000
The following slide deck was published by ARCA biopharma, Inc. in conjunction with this Read more … read more...
ARCA biopharma (ABIO) Top-Line Data From Genetic-AF Phase 2B Clinical Trial - Slideshow'
via: SeekingAlpha at 2018-02-27 13:50:17:000
The following slide deck was published by ARCA biopharma, Inc. in conjunction with this Read more … read more...
Your Daily Pharma Scoop: Progenics Update, La Jolla Data, ARCA Biopharma Setback
via: SeekingAlpha at 2018-02-27 08:00:00:000
Analysis of top Seeking Alpha coverage: Progenics Today we will discuss Progenics Pharmaceuticals ( PGNX ), which last week presented at the RBC Capital Markets Global Healthcare Conference. As we have noted before, Progenics has an important upcoming catalyst, which could provide a si… read more...
Your Daily Pharma Scoop: Progenics Update, La Jolla Data, ARCA Biopharma Setback
via: SeekingAlpha at 2018-02-27 08:00:00:000
Analysis of top Seeking Alpha coverage: Progenics Today we will discuss Progenics Pharmaceuticals ( PGNX ), which last week presented at the RBC Capital Markets Global Healthcare Conference. As we have noted before, Progenics has an important upcoming catalyst, which could provide a si… read more...
Your Daily Pharma Scoop: Progenics Update, La Jolla Data, ARCA Biopharma Setback
via: SeekingAlpha at 2018-02-27 08:00:00:000
Analysis of top Seeking Alpha coverage: Progenics Today we will discuss Progenics Pharmaceuticals ( PGNX ), which last week presented at the RBC Capital Markets Global Healthcare Conference. As we have noted before, Progenics has an important upcoming catalyst, which could provide a si… read more...
Midday Gainers / Losers (2/26/2018)
via: SeekingAlpha at 2018-02-26 12:49:58:000
Gainers: NXTD +30% . TAHO +20% . RCM +20% . ZSAN +18% . TTPH +18% . APLS +16% . XTNT +15% . DTRM +14% . CGEN +14% . ACHN +14% . More news on: NXT-ID Inc., Tahoe Resources Inc., R1 RCM Inc., Stocks on the move, , Read more … read more...
Midday Gainers / Losers (2/26/2018)
via: SeekingAlpha at 2018-02-26 12:49:58:000
Gainers: NXTD +30% . TAHO +20% . RCM +20% . ZSAN +18% . TTPH +18% . APLS +16% . XTNT +15% . DTRM +14% . CGEN +14% . ACHN +14% . More news on: NXT-ID Inc., Tahoe Resources Inc., R1 RCM Inc., Stocks on the move, , Read more … read more...
Midday Gainers / Losers (2/26/2018)
via: SeekingAlpha at 2018-02-26 12:49:58:000
Gainers: NXTD +30% . TAHO +20% . RCM +20% . ZSAN +18% . TTPH +18% . APLS +16% . XTNT +15% . DTRM +14% . CGEN +14% . ACHN +14% . More news on: NXT-ID Inc., Tahoe Resources Inc., R1 RCM Inc., Stocks on the move, , Read more … read more...
Premarket Losers as of 9:05 am (2/26/2018)
via: SeekingAlpha at 2018-02-26 09:08:55:000
ABIO -57% on underwhelming mid-stage Gencaro data. More news on: ARCA biopharma, Inc., Dean Foods Company, TAL Education Group, Stocks on the move, , Read more … read more...
Premarket Losers as of 9:05 am (2/26/2018)
via: SeekingAlpha at 2018-02-26 09:08:55:000
ABIO -57% on underwhelming mid-stage Gencaro data. More news on: ARCA biopharma, Inc., Dean Foods Company, TAL Education Group, Stocks on the move, , Read more … read more...
ARCA down 60% premarket on underwhelming mid-stage Gencaro data
via: SeekingAlpha at 2018-02-26 09:04:42:000
Thinly traded nano cap ARCA biopharma (NASDAQ: ABIO ) slumps 60% premarket on increased volume in response to its announcement of results from a Phase 2 clinical trial, GENETIC-AF , evaluating Gencaro (bucindolol hydrochloride) for the the treatment of atrial fibrillation (AF)… read more...
ARCA down 60% premarket on underwhelming mid-stage Gencaro data
via: SeekingAlpha at 2018-02-26 09:04:42:000
Thinly traded nano cap ARCA biopharma (NASDAQ: ABIO ) slumps 60% premarket on increased volume in response to its announcement of results from a Phase 2 clinical trial, GENETIC-AF , evaluating Gencaro (bucindolol hydrochloride) for the the treatment of atrial fibrillation (AF)… read more...
ARCA Bio nabs European patent covering candidate AB171; shares ahead 25%
via: SeekingAlpha at 2017-11-16 10:40:39:000
Thinly traded nano cap ARCA biopharma ( ABIO +25% ) jumps on a healthy 23x surge in volume in response to its announcement that the European Patent Office has issued it a new patent covering methods of treating cardiovascular disease and conditions with a thiol-substituted isosorbide mon… read more...
Premarket Gainers as of 9:05 am
via: SeekingAlpha at 2017-11-16 09:26:39:000
CADC +198% . More news on: China Advanced Construction Materials Group, Inc., SemiLEDs Corporation, Time Inc., Stocks on the move, Read more … read more...
Your Daily Pharma Scoop: Neurocrine Has Upside, Dynavax Gets FDA Nod, Sage Soars
via: SeekingAlpha at 2017-11-12 00:20:46:000
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Neurocrine Biosciences Today we will d… read more...
ARCA biopharma reports Q3 results
via: SeekingAlpha at 2017-11-09 17:09:08:000
ARCA biopharma (NASDAQ: ABIO ): Q3 EPS of -$0.39 Cash and equivalents of $16M Press Release More news on: ARCA biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , read more...
ARCA biopharma (ABIO) Presents At The Sidoti & Company Fall 2017 Convention - Slideshow
via: SeekingAlpha at 2017-09-29 13:39:55:000
The following slide deck was published by ARCA biopharma, Inc. in conjunction with this Read more … read more...
ARCA bio's mid-stage study of Gencaro in atrial fibrillation to continue as planned; shares ahead 9% after hours
via: SeekingAlpha at 2017-08-09 17:04:35:000
Thinly traded nano cap ARCA biopharma (NASDAQ: ABIO ) is up 9% on increased volume on the news that the independent Data and Safety Monitoring Board (DSMB) has completed its pre-planned interim analysis of the company's Phase 2b clinical trial, GENETIC-AF, evaluating Gencaro (b… read more...
ARCA bio slumps in mid-session trade, shares down 12%
via: SeekingAlpha at 2017-07-27 13:24:09:000
Thinly traded nano cap ARCA biopharma ( ABIO -11.6% ) was treating water today until recent trading dropped shares as low as $1.90. Volume is below average so far. More news on: ARCA biopharma, Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Daily Insider Ratings Round Up 7/17/17: IFF, OPK, MHH, MERC, NEP
via: SeekingAlpha at 2017-07-18 12:45:51:000
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC yesterday. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Significant" in… read more...
ARCA biopharma Announces 200th Patient Randomized into the GENETIC-AF Seamless Design Phase 2B/3 Clinical Trial
via: Business Wire at 2017-04-26 08:30:00:000
Outcome of Phase 2B Interim Efficacy Analysis Anticipated in September 2017 80% of Phase 2B Planned Patient Enrollment Completed ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies fo… read more...
ARCA biopharma to Present at the Planet MicroCap Showcase 2017 Investor Conference
via: Business Wire at 2017-04-18 08:30:00:000
ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that it will present a corporate overview at the Planet MicroCap Showcase 2017 Investor Conference… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2015-09-04 | 7.0 | 1.0 | 7.0 | |||
| 2013-03-05 | 6.0 | 1.0 | 6.0 |